Página 3 - Melhores Leucemia Leucemia - TOP-83 médicos

O Prof. Hasan Atilla Özkan é especialista no tratamento da leucemia, com mais de 20 anos de experiência em hematologia e vasta experiência em transplante de medula óssea.

• Atualmente Professor na Faculdade de Medicina da Universidade Yeditepe
• Presidente da Associação Turca de Aférese Terapêutica
• Certificado em Transplante de Células-Tronco Autólogas e Alogênicas
• Membro da EBMT (European Bone Marrow Transplantation)

Listado entre os melhores médicos de Israel pela Forbes, o Dr. Gal Goldstein lidera o Departamento de Oncologia e Hemato-Oncologia Pediátrica do Hadassah Medical Center.

• Mais de 20 anos de especialização em hemato-oncologia pediátrica
• Especialista em transplante haploidêntico de medula óssea
• Foco em retinoblastoma e medicina de precisão
• Membro de quatro associações internacionais de oncologia pediátrica
• Formado pela Universidade de Tel Aviv

O Dr. Eckhart Weidmann chefia o setor de Hematologia da Clínica Nordwest, especializando-se no tratamento de doenças do sangue com mais de 30 anos de prática.

• Um dos melhores médicos para linfoma não-Hodgkin
• Professor com ampla experiência acadêmica e clínica
• Focar em distúrbios sanguíneos complexos

O Dr. Alemdar é especialista no tratamento de Leucemia, trazendo uma vasta experiência académica e hospitalar para a sua prática no Complexo Hospitalar Medical Park Antalya.

• Certificação em Oncologia Médica pela Universidade de Akdeniz
• Anos de experiência em hospitais universitários de topo, incluindo o Hospital Universitário de Akdeniz
• Formação abrangente em Medicina Interna antes da especialização em Oncologia

A Professora Zila Zuckerman é uma dedicada especialista em hematologia e transplantologia no Rambam Medical Center.

• Especialista em cancros do sangue em adultos e crianças
• Focada em transplante de medula óssea para leucemia
• Membro da equipa de um importante centro médico académico

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

A Dra. Stepensky realizou mais de 3.500 transplantes de medula óssea e foi reconhecida pela Forbes como uma das melhores médicas.

• Especializar-se no tratamento de crianças com leucemia e cancros do sangue raros
• 20 anos de prática dedicada em hematologia pediátrica
• Doentes e pais chamam-lhe a médica que «transplanta a vida»

O Dr. Spielberg é um onco-hematologista especializado em cancros do sangue no Assuta Medical Center.

• Especialização focada especificamente em leucemia e outros distúrbios sanguíneos
• Sediado no proeminente hospital privado de Israel, o Assuta Medical Center
• Prestar cuidados integrados de oncologia com acesso a diagnósticos avançados

Chefia o Departamento de Hematologia do Hadassah Medical Center, onde se especializa em tratamentos avançados para cancros do sangue.

• Professora com mais de três décadas de experiência em doenças malignas do sangue
• Formada durante três anos no Memorial Sloan-Kettering Cancer Center, em Nova Iorque
• Especialista em transplante de medula óssea e novas terapias génicas
• Primeira mulher a exercer o cargo de Diretora da Faculdade de Medicina de Hadassah
• Recebeu o prémio Healing with the Heart pelo cuidado excecional ao paciente

O Prof. Bosch lidera a investigação global em Leucemia Linfocítica Crónica (LLC), com mais de 80 ensaios clínicos ativos no desenvolvimento de novos tratamentos.

• Especializar-se em LLC e distúrbios linfoproliferativos desde 2000
• Presidente do grupo de estudo espanhol de LLC (GELLC)
• Publicar mais de 100 artigos em revistas de renome como o NEJM e a Nature Medicine
• Fellowship no Instituto de Genética do Cancro da Universidade de Columbia

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Prof. Dr. Serdar Bedii Omay publicou mais de 65 artigos científicos sobre hematologia e transplante de medula óssea, com vasta experiência nas Universidades de Hacettepe e Ege.

• Especializar-se em hematologia na Mie Medical School do Japão
• Professor de Hematologia na Karadeniz Technical University
• Mais de 30 anos de experiência em hematologia
• Escrever 112 artigos de reuniões e 34 apresentações em conferências